Don S. Anson

2.1k citations

32 papers · 1.8k · h-index 21

Impact in

Hematology top 2%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
Physiology top 5%
- Lysosomal Storage Disorders Research

Papers in

Genetics 14
- Virus-based gene therapy research 13
- Animal Genetics and Reproduction 3
Hematology 7
- Hemophilia Treatment and Research 6

Co-authors: John J. Hopwood (9 shared papers)G.G. Brownlee (4 shared papers)Julie Bielicki (5 shared papers)Charles Phillip Morris (4 shared papers)Francesco Giannelli (2 shared papers)K.H. Andy Choo (2 shared papers)Peter Roy Clements (2 shared papers)Peter J. Wilson (2 shared papers)
Journals: Biochemical Journal (5 papers)The Journal of Gene Medicine (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (2 papers)The EMBO Journal (2 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

Don S. Anson

32 papers receiving 1.6k citations

Peers

Replace Elizabeth A. Eklund with:

Elizabeth A. Eklund United States

Emilie H. Mules United States

Hung Do United States

Carmen B. Lozzio United States

Lynne Lacomis United States

Cheryl A. Whitlock United States

Stefan P. Glaser Australia

Seong-Ryeong Go Japan

T Kojima Japan

M B Prystowsky United States

Don S. Anson relative to Elizabeth A. Eklund United States Elizabeth A. Eklund's profile →

Citations per field

00.5×2×3×4.0×

Elizabeth A. Eklund · 1×

×0.8 478/602

HEMAT

×4.0 632/159

PHYSI

×0.8 188/224

GENET

×2.5 380/152

GENET

×0.5 811/2k

MB

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by Don S. Anson

Since Specialization

Citations

This map shows the geographic impact of Don S. Anson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don S. Anson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don S. Anson more than expected).

Fields of papers citing papers by Don S. Anson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don S. Anson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don S. Anson. The network helps show where Don S. Anson may publish in the future.

Co-authors

The 25 scholars most cited alongside Don S. Anson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Don S. Anson Line = papers co-authored together Don S. Anson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The gene structure of human anti‐haemophilic factor IX. The EMBO Journal ·Don S. Anson, K.H. Andy Choo, David Jasper G. Rees, Francesco Giannelli, Keith G. Gould, Joyce A. Huddleston, G.G. Brownlee	1984	330
2	Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proceedings of the National Academy of Sciences ·Peter J. Wilson, Charles Phillip Morris, Don S. Anson, Teresa Occhiodoro, Julie Bielicki, Peter Roy Clements, John J. Hopwood	1990	243
3	Human alpha-L-iduronidase: cDNA isolation and expression. Proceedings of the National Academy of Sciences ·Hamish S. Scott, Don S. Anson, Annette Orsborn, Paul V. Nelson, Peter Roy Clements, Charles Phillip Morris, John J. Hopwood	1991	133
4	Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms Nucleic Acids Research ·Peter R. Winship, Don S. Anson, Charles R. Rizza, George G. Brownlee	1984	124
5	Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. Journal of Clinical Investigation ·Allison C. Crawley, Doug A. Brooks, Vivienne J. Muller, B A Petersen, Elizabeth L. Isaac, Julie Bielicki, Barbara M. King, Christine D Boulter	1996	119
6	CHARACTERISATION AND USE OF AN INTRAGENIC POLYMORPHIC MARKER FOR DETECTION OF CARRIERS OF HAEMOPHILIA B (FACTOR IX DEFICIENCY) The Lancet ·Francesco Giannelli, K.H. Andy Choo, Peter R. Winship, Charles R. Rizza, Don S. Anson, Dai G., Nicolas Ferrari, G.G. Brownlee	1984	112
7	Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells Nature ·Don S. Anson, D. E. G. Austen, G.G. Brownlee	1985	82
8	Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme Biochemical Journal ·Julie Bielicki, John J. Hopwood, Peter J. Wilson, Don S. Anson	1993	60
9	Recombinant α- l -iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts Biochemical Journal ·E G Unger, J.L. Durrant, Don S. Anson, John J. Hopwood	1994	55
10	Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length Respiratory Research ·Patricia Cmielewski, Don S. Anson, David Parsons	2010	46
11	Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production The Journal of Gene Medicine ·Rachel M. Koldej, Patricia Cmielewski, Alice G. Stocker, David Parsons, Don S. Anson	2005	39
12	Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Proceedings of the National Academy of Sciences ·LJ Fairbairn, L. S. Lashford, Elaine Spooncer, R. H. McDermott, G. Lebens, Janet E. Arrand, J. R. Arrand, Ilaria Bellantuono	1996	38
13	Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase Biochemical Journal ·Julie Bielicki, Maria Fuller, X H Guo, Charles Phillip Morris, J J Hopewood, Don S. Anson	1995	35
14	Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein Biochemical Journal ·Doug A. Brooks, D A Robertson, Colleen A. Bindloss, Tom Litjens, Don S. Anson, C Peters, Charles Phillip Morris, John J. Hopwood	1995	32
15	Lentivirus-mediated gene transfer to the rat, ovine and human cornea Gene Therapy ·Douglas G Parker, Claude Kaufmann, Helen Mary Brereton, Don S. Anson, L Francis-Staite, Claire F. Jessup, Khiya Marshall, C Tan	2007	32
16	Rational development of a HIV‐1 gene therapy vector The Journal of Gene Medicine ·Don S. Anson, Maria Fuller	2003	31
17	Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII Molecular Genetics and Metabolism ·Carmen E. Macsai, Ainslie L.K. Derrick‐Roberts, Xiaodan Ding, Krystyna H. Zarrinkalam, Chantelle McIntyre, Paul Anderson, Don S. Anson, Sharon Byers	2012	29
18	Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. Journal of Clinical Investigation ·Reginald James Matthews, Don S. Anson, I R Peake, A L Bloom	1987	27
19	Towards gene therapy for hemophilia B. PubMed ·Don S. Anson, Randy A. Hock, D. E. G. Austen, Keith J. Smith, G. G. Brownlee, Inder M. Verma, A. Dusty Miller	1987	26
20	Overexpression of N-acetylgalactosamine-4-sulphatase induces a multiple sulphatase deficiency in mucopolysaccharidosis-type-VI fibroblasts Biochemical Journal ·Don S. Anson, Volker Müller, Julie Bielicki, Gregory S. Harper, John J. Hopwood	1993	25

About Don S. Anson

Don S. Anson is a scholar working on Genetics, Hematology, Physiology, Molecular Biology and Biotechnology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Lysosomal Storage Disorders Research (10 papers), Hemophilia Treatment and Research (6 papers), RNA Interference and Gene Delivery (5 papers), CRISPR and Genetic Engineering (4 papers), Glycosylation and Glycoproteins Research (4 papers), Cancer-related gene regulation (4 papers) and Animal Genetics and Reproduction (3 papers). The work is most often cited by research in Hematology (478 citations), Physiology (632 citations), Genetics (188 citations), Genetics (380 citations) and Molecular Biology (811 citations). Don S. Anson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include John J. Hopwood, G.G. Brownlee, Julie Bielicki, Charles Phillip Morris, Francesco Giannelli, K.H. Andy Choo, Peter Roy Clements, Peter J. Wilson, Peter R. Winship and Keith G. Gould. Their work appears in journals such as Biochemical Journal, The Journal of Gene Medicine, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Don S. Anson

Impact in

Papers in i

In The Last Decade

Don S. Anson

Peers

Countries citing papers authored by Don S. Anson

Fields of papers citing papers by Don S. Anson

All Works

About Don S. Anson

Explore authors with similar magnitude of impact

Papers in